Evidence map›Paper›PMID 42939454›Full record

ArticleBiology2026

Xinyan Deng, Haixiang Ma, Jiajie Zhang, Xiyang Huang, Minghong Cai, Fanghui Ge, Hong Zhang, Jiandong Wang

Abstract read
In one paragraph

Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xinyan DengSichuan Provincial Engineering Laboratory for Prevention and Control Technology of Veterinary Drug Residue in Animal-Origin Food, School of Laboratory Medicine, Chengdu Medical College, Chengdu 610500, China.
Haixiang MaSichuan Provincial Engineering Laboratory for Prevention and Control Technology of Veterinary Drug Residue in Animal-Origin Food, School of Laboratory Medicine, Chengdu Medical College, Chengdu 610500, China.
Jiajie ZhangSichuan Provincial Engineering Laboratory for Prevention and Control Technology of Veterinary Drug Residue in Animal-Origin Food, School of Laboratory Medicine, Chengdu Medical College, Chengdu 610500, China.
Xiyang HuangSichuan Provincial Engineering Laboratory for Prevention and Control Technology of Veterinary Drug Residue in Animal-Origin Food, School of Laboratory Medicine, Chengdu Medical College, Chengdu 610500, China.
Minghong CaiSchool of Bioscience and Technology, Chengdu Medical College, Chengdu 610500, China.
Fanghui GeSichuan Provincial Engineering Laboratory for Prevention and Control Technology of Veterinary Drug Residue in Animal-Origin Food, School of Laboratory Medicine, Chengdu Medical College, Chengdu 610500, China.
Hong ZhangSichuan Provincial Engineering Laboratory for Prevention and Control Technology of Veterinary Drug Residue in Animal-Origin Food, School of Laboratory Medicine, Chengdu Medical College, Chengdu 610500, China.
Jiandong WangSchool of Bioscience and Technology, Chengdu Medical College, Chengdu 610500, China.ORCID 0000-0002-4694-423X

Funding

Chengdu Medical College CYZZD24-09
6 · The paper itself

Abstract

Despite substantial advances in diagnosis and treatment, breast malignancy continues to cause considerable morbidity and mortality. Cisplatin has demonstrated therapeutic activity in selected patients with advanced breast cancer, but its clinical use may be limited by treatment resistance. Although

Indexed as

ARMCX3breast cancercisplatin sensitivityp53 signaling

Identifiers

PMID42939454
PMCPMC13701251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.